$KPTI
Karyopharm Therapeutics Inc.

2020 Q3 Form 10-Q Financial Statement

#000156459020036120 Filed on August 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q4
Revenue $21.33M $33.51M $18.10M
YoY Change 62.23% 253.04% 8686.41%
Cost Of Revenue $440.0K $400.0K $1.390M
YoY Change -56.44%
Gross Profit $20.90M $33.12M $16.70M
YoY Change 72.16%
Gross Profit Margin 97.97% 98.82% 92.27%
Selling, General & Admin $30.97M $30.84M $28.39M
YoY Change 22.56% 25.06% 51.25%
% of Gross Profit 148.17% 93.13% 170.0%
Research & Development $37.04M $42.59M $31.58M
YoY Change 40.99% 60.63% -18.8%
% of Gross Profit 177.21% 128.61% 189.1%
Depreciation & Amortization $240.0K $240.0K $240.0K
YoY Change 0.0% 0.0% 20.0%
% of Gross Profit 1.15% 0.72% 1.44%
Operating Expenses $68.44M $73.83M $59.97M
YoY Change 30.24% 44.26% 4.0%
Operating Profit -$47.11M -$40.32M -$43.27M
YoY Change 19.56% -3.28% -24.69%
Interest Expense $6.801M $6.758M -$5.370M
YoY Change 119.88% 118.78% 635.62%
% of Operating Profit
Other Income/Expense, Net -$6.342M -$5.970M -$10.00K
YoY Change 225.9% 246.89% -98.68%
Pretax Income -$53.45M -$46.29M -$48.65M
YoY Change 29.27% 6.64% -16.39%
Income Tax $44.00K $137.0K $0.00
% Of Pretax Income
Net Earnings -$53.50M -$46.43M -$48.65M
YoY Change 29.32% 6.94% -16.42%
Net Earnings / Revenue -250.76% -138.53% -268.78%
Basic Earnings Per Share
Diluted Earnings Per Share -$728.2K -$633.9K -$761.0K
COMMON SHARES
Basic Shares Outstanding 73.48M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $263.0M $296.7M $262.0M
YoY Change -1.68% 36.61% -20.18%
Cash & Equivalents $82.30M $103.1M $128.9M
Short-Term Investments $180.7M $193.6M $133.1M
Other Short-Term Assets $9.300M $9.900M $8.400M
YoY Change 75.47% 73.68% 31.25%
Inventory $2.011M $1.652M $346.0K
Prepaid Expenses
Receivables $11.10M $9.600M $7.900M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $285.4M $317.8M $278.6M
YoY Change 1.6% 42.66% -16.75%
LONG-TERM ASSETS
Property, Plant & Equipment $12.10M $2.592M $3.046M
YoY Change -14.18% -82.25% -21.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $39.40M $48.90M $2.000M
YoY Change 1870.0% 0.0%
Other Assets $700.0K $700.0K $700.0K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $52.20M $62.18M $16.39M
YoY Change 210.71% 306.37% 149.13%
TOTAL ASSETS
Total Short-Term Assets $285.4M $317.8M $278.6M
Total Long-Term Assets $52.20M $62.18M $16.39M
Total Assets $337.6M $380.0M $295.0M
YoY Change 13.4% 59.6% -13.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.400M $1.888M $985.0K
YoY Change -22.58% 71.64% -77.26%
Accrued Expenses $48.40M $45.98M $40.88M
YoY Change 42.35% 56.92% 25.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $52.60M $50.57M $46.35M
YoY Change 34.18% 57.05% -1.18%
LONG-TERM LIABILITIES
Long-Term Debt $189.4M $187.4M $183.4M
YoY Change 4.3% 76.46% 78.58%
Other Long-Term Liabilities $11.80M $12.30M $15.40M
YoY Change -30.99% -28.9% 81.18%
Total Long-Term Liabilities $201.2M $199.7M $198.8M
YoY Change 1.26% 61.7% 78.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.60M $50.57M $46.35M
Total Long-Term Liabilities $201.2M $199.7M $198.8M
Total Liabilities $253.8M $250.2M $245.2M
YoY Change 6.68% 60.8% 55.16%
SHAREHOLDERS EQUITY
Retained Earnings -$972.7M -$873.3M
YoY Change 29.62%
Common Stock $1.102B $923.1M
YoY Change 7.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $83.77M $129.8M $49.77M
YoY Change
Total Liabilities & Shareholders Equity $337.6M $380.0M $295.0M
YoY Change 13.4% 59.6% -13.55%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q4
OPERATING ACTIVITIES
Net Income -$53.50M -$46.43M -$48.65M
YoY Change 29.32% 6.94% -16.42%
Depreciation, Depletion And Amortization $240.0K $240.0K $240.0K
YoY Change 0.0% 0.0% 20.0%
Cash From Operating Activities -$44.31M -$40.28M -$39.49M
YoY Change 21.4% -16.45% -18.02%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$20.00K -$50.00K
YoY Change -100.0% -95.41%
Acquisitions
YoY Change
Other Investing Activities $21.43M -$60.02M -$33.47M
YoY Change -46.81% -250.8% -67.19%
Cash From Investing Activities $21.43M -$60.03M -$33.52M
YoY Change -46.67% -250.83% -67.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.240M 2.050M 34.94M
YoY Change -98.6% 412.5% -79.18%
NET CHANGE
Cash From Operating Activities -44.31M -40.28M -39.49M
Cash From Investing Activities 21.43M -60.03M -33.52M
Cash From Financing Activities 1.240M 2.050M 34.94M
Net Change In Cash -21.64M -98.26M -38.07M
YoY Change -123.39% 1126.72% -330.73%
FREE CASH FLOW
Cash From Operating Activities -$44.31M -$40.28M -$39.49M
Capital Expenditures $0.00 -$20.00K -$50.00K
Free Cash Flow -$44.31M -$40.26M -$39.44M
YoY Change 21.76% -16.49% -16.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36167
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1117000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
317836000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001503802
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3931704
dei Entity Address City Or Town
EntityAddressCityOrTown
Newton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02459
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
658-0600
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
KPTI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
73478203
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103102000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
128858000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
193615000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
133098000
CY2020Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
9581000
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
7862000
CY2020Q2 us-gaap Inventory Net
InventoryNet
1652000
CY2019Q4 us-gaap Inventory Net
InventoryNet
346000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7971000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7289000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1915000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
278570000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2592000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3046000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10013000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10617000
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1412000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1824000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3183000
CY2020Q2 us-gaap Interest Expense
InterestExpense
6758000
us-gaap Operating Income Loss
OperatingIncomeLoss
-106608000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
849000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Address Address Line1
EntityAddressAddressLine1
85 Wells Avenue, 2nd Floor
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
48856000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
2016000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
714000
CY2020Q2 us-gaap Assets
Assets
380011000
CY2019Q4 us-gaap Assets
Assets
294963000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73366000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65370000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65370000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
7000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1101596000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
923142000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
891000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-972695000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-873338000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33514000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9493000
CY2020Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
396000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1215000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42594000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26517000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
76591000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64491000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30843000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24662000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61521000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51765000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
73833000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
51179000
us-gaap Operating Expenses
OperatingExpenses
139327000
us-gaap Operating Expenses
OperatingExpenses
116256000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-40319000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-41686000
us-gaap Operating Income Loss
OperatingIncomeLoss
-87675000
CY2019Q2 us-gaap Interest Expense
InterestExpense
3089000
us-gaap Interest Expense
InterestExpense
13267000
us-gaap Interest Expense
InterestExpense
6087000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-61000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
714000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1888000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
985000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45979000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40878000
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
297000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2341000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1778000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1646000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
628000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
500000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
50570000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
46350000
CY2020Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
113776000
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
109857000
CY2020Q2 kpti Deferred Royalty Obligation Noncurrent
DeferredRoyaltyObligationNoncurrent
73588000
CY2019Q4 kpti Deferred Royalty Obligation Noncurrent
DeferredRoyaltyObligationNoncurrent
73588000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12278000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13202000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2192000
CY2020Q2 us-gaap Liabilities
Liabilities
250212000
CY2019Q4 us-gaap Liabilities
Liabilities
245189000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73366000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
129799000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
49774000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
380011000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
294963000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51652000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9648000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
203000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-36000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5970000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1721000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11479000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-46426000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-43415000
us-gaap Net Income Loss
NetIncomeLoss
-99357000
us-gaap Net Income Loss
NetIncomeLoss
-109576000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2950000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46289000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43407000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-99154000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-109558000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
137000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.63
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.41
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.80
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73237
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60929
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70475
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60893
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-46426000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-43415000
us-gaap Net Income Loss
NetIncomeLoss
-99357000
us-gaap Net Income Loss
NetIncomeLoss
-109576000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1273000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
52000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
959000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
309000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
37000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-31000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45115000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43326000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-98429000
us-gaap Profit Loss
ProfitLoss
-99357000
us-gaap Profit Loss
ProfitLoss
-109576000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
480000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
487000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-89000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
968000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3919000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3493000
us-gaap Share Based Compensation
ShareBasedCompensation
11580000
us-gaap Share Based Compensation
ShareBasedCompensation
8023000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1719000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1306000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
682000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-742000
kpti Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-605000
kpti Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-531000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
903000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3171000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
5228000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11580000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
161802000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
959000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-31000
us-gaap Net Income Loss
NetIncomeLoss
-99357000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-4580000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4236000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-9362000
kpti Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-792000
kpti Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-446000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-85288000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-114827000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
99286000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
118511000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
205773000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
46668000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-106513000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
71794000
kpti Proceeds From Payments For Common Stock Issuance Net
ProceedsFromPaymentsForCommonStockIssuanceNet
161803000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5072000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
547000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
166875000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
547000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-32000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24958000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42477000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130689000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118737000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105731000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76260000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103102000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75545000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1915000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
714000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
715000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11711000
kpti Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
1592000
kpti Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
1319000
us-gaap Payments For Royalties
PaymentsForRoyalties
2400000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
166147000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2339000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6428000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1273000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-46426000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
129799000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
121284000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
395000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4116000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
52000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
37000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-43415000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
82469000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
49774000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5072000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
129799000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
183170000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
547000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8023000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
309000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4000
us-gaap Net Income Loss
NetIncomeLoss
-109576000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
82469000
CY2020Q2 kpti Revenue Recognition Decrease Increase In Product Revenue
RevenueRecognitionDecreaseIncreaseInProductRevenue
3600000
kpti Revenue Recognition Decrease Increase In Product Revenue
RevenueRecognitionDecreaseIncreaseInProductRevenue
6400000
CY2020Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
9600000
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
7900000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q2 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
34
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
44000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
135114000
CY2020Q2 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
1350000
CY2019Q4 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
273000
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
302000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
73000
CY2020Q2 us-gaap Inventory Net
InventoryNet
1652000
CY2019Q4 us-gaap Inventory Net
InventoryNet
346000
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1300000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2341000
kpti Deferred Revenue Current Period Increase
DeferredRevenueCurrentPeriodIncrease
297000
kpti Deferred Revenue Current Period Decrease
DeferredRevenueCurrentPeriodDecrease
2341000
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
297000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2192000
kpti Deferred Revenue Noncurrent Period Decrease
DeferredRevenueNoncurrentPeriodDecrease
2192000
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
4533000
kpti Deferred Revenue Increase
DeferredRevenueIncrease
297000
kpti Deferred Revenue Decrease
DeferredRevenueDecrease
4533000
CY2020Q2 us-gaap Deferred Revenue
DeferredRevenue
297000
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
298276000
CY2020Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
2300000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
206494000
CY2019Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
2300000
CY2020Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
241518000
CY2020Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
996000
CY2020Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
43000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
242471000
CY2019Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
135121000
CY2020Q2 kpti Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Other Than Temporary Impairments
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxOtherThanTemporaryImpairments
0
CY2019Q4 kpti Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Other Than Temporary Impairments
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxOtherThanTemporaryImpairments
0
CY2019Q4 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
27
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
83770000
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
43000
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
83770000
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
43000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6428000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4116000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11580000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8023000
CY2018Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1
kpti Debt Instrument Convertible Threshold Measurement Period Description
DebtInstrumentConvertibleThresholdMeasurementPeriodDescription
during the five business day period immediately after any five consecutive trading day
kpti Principal Amount Of Notes Used In Conversion Rate
PrincipalAmountOfNotesUsedInConversionRate
1000
kpti Debt Instrument Convertible Threshold Maximum Percentage Of Product Of Last Reported Sale Price Of Common Stock
DebtInstrumentConvertibleThresholdMaximumPercentageOfProductOfLastReportedSalePriceOfCommonStock
0.98
us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
5
CY2020Q2 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
67900000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
172500000
CY2020Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
104700000
us-gaap Debt Instrument Term
DebtInstrumentTerm
P7Y
us-gaap Debt Instrument Convertible If Converted Value In Excess Of Principal
DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
0
CY2020Q2 kpti Debt Instrument Estimated Fair Value
DebtInstrumentEstimatedFairValue
243700000

Files In Submission

Name View Source Status
0001564590-20-036120-index-headers.html Edgar Link pending
0001564590-20-036120-index.html Edgar Link pending
0001564590-20-036120.txt Edgar Link pending
0001564590-20-036120-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kpti-10q_20200630.htm Edgar Link pending
kpti-10q_20200630_htm.xml Edgar Link completed
kpti-20200630.xsd Edgar Link pending
kpti-20200630_cal.xml Edgar Link unprocessable
kpti-20200630_def.xml Edgar Link unprocessable
kpti-20200630_lab.xml Edgar Link unprocessable
kpti-20200630_pre.xml Edgar Link unprocessable
kpti-ex101_116.htm Edgar Link pending
kpti-ex311_8.htm Edgar Link pending
kpti-ex312_7.htm Edgar Link pending
kpti-ex321_9.htm Edgar Link pending
kpti-ex322_6.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending